Clinical Trial Update: Open-label Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Auriхim [Phase 1]

View source ↗

Summary

Open-label Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of Aurixim in lymphoma patients; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Aurixim

Snippet

Sponsor: Biointegrator LLC | Conditions: Lymphoma, Non-Hodgkin, Lymphoma, Follicular | Phase 1 | Status: COMPLETED